Loading
Xiaojun Huang built the Beijing Protocol for stem cell transplants from half-matched family donors, which means almost every Chinese leukaemia patient can now find a donor.
Huang's group developed haploidentical transplantation without in vitro T-cell depletion using G-CSF-primed grafts and anti-thymocyte globulin (Bone Marrow Transplantation 2006), now the most common transplant type in China and increasingly used worldwide; his centre performs more haploidentical transplants than any other. Later work covers relapse prevention, GVHD and CAR-T bridging to transplant. Academician of the Chinese Academy of Engineering.
| Title | Journal | Year |
|---|---|---|
| Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies | Bone Marrow Transplantation | 2006 |
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tag china.
Shares Acute myeloid leukaemia and the tag china.
Shares Acute myeloid leukaemia and the tag china.
Shares Acute lymphoblastic leukaemia and the tag china.
Shares Acute lymphoblastic leukaemia and the tag china.
Shares Graft-versus-host disease (GVHD) and graft-versus-leukaemia, Allogeneic stem cell transplant (allo-SCT), Allogeneic (off-the-shelf) cell therapy.
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.